Now, Ramya Canteen to provide food at subsidised rates

Mangaluru, Apr 7: The virology lab set up in Wenlock Hospital here to test COVID-19 samples will start functioning from Tuesday, Karnataka District in-charge Minister Kota Srinivas Poojary said.

In his tweeter Mr Poojary said “After receiving approval from the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV), the Virology Research and Diagnostic Laboratory set up at district Wenlock will start operating from April 7. The samples for COVID-19 will be tested in the district itself. I thank the state government for helping us set up the lab.”

The new Lab becomes the 10th government lab for testing COVID-19 samples in the state.

Bengaluru, May 19: Karnataka State Road Transport Corporation (KSRTC) has begun booking of tickets from May 18. Ticket counters have been opened after implementation of new guidelines for the fourth phase of COVID-19 nationwide lockdown.

People seeking to travel can book the tickets through KSRTC booking counters, authorised franchises booking counters and online, mobile booking, according to a release.

The advanced booking has started for Bengaluru-Shivamogga, Bengaluru-Mysuru, Bengaluru-Mangaluru routes, among others.

Bookings can be made upto 30 days in advance, as per the release.

Amid COVID-19, Bengaluru Metropolitan Transport Corporation has restricted the operation services of the bus between 7 AM to 7 PM, said the release.

Passengers are permitted to travel with social distancing measures while the transport corporation will follow the standard operating procedure issued by the Ministry of Home Affairs.

The MHA had issued updated guidelines after the implementation of the fourth phase of nationwide lockdown on May 17th.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.